GLMD Stock Analysis: Buy, Sell, or Hold?
GLMD - Galmed Pharmaceuticals Ltd.
$0.51
-0.03 (-4.75%)
▼
5d:
-10.14%
30d:
-16.98%
90d:
-32.71%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 27, 2026
Get Alerted When GLMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called GLMD this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: GLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: GLMD shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: GLMD is currently trading at $0.51, which is considered oversold relative to its 30-day fair value range of $0.53 to $0.62.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+2135.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, GLMD is in a downtrend. Immediate support is located at $0.41, while resistance sits at $0.79. Short-term momentum is weak, with the stock down 4.8% recently.
Market Sentiment: GLMD has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $12.00 (+2135.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.53 -
$0.62
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.8%)
- BULLISH: Trading 2135.5% below Wall St target ($12.00)
- CAUTION: 5-day price weakness (-10.1%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.53 -
$0.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.42
Resistance Level
$0.79
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.60
Wall Street Target
$12.00
(+2135.5%)
Share & Embed Analysis
Last updated: July 14, 2026 1:47 PM ET
Data refreshes hourly during market hours. Next update: 2:47 PM
Data refreshes hourly during market hours. Next update: 2:47 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$441 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 62 BUY |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 61 BUY |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 61 BUY |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 59 HOLD |
